Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $4.7350 (4.3%) ($4.7350 - $4.7350) on Thu. Sep. 8, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 10.71% (three month average) | RSI | 49 | Latest Price | $4.7350(4.3%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 3.3% a day on average for past five trading days. | Weekly Trend | ATRA advances 0.3% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) IBB(85%) IDRV(73%) SPLV(91%) SDY(73%) IWD(68%) | Factors Impacting ATRA price | ATRA will decline at least -5.355% in a week (0% probabilities). XME(-46%) OIH(-37%) UUP(-32%) TBT(-39%) XLE(-30%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -5.355% (StdDev 10.71%) | Hourly BBV | 1.5 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $4.43(6.88%) | 10 Day Moving Average | $4.29(10.37%) | 20 Day Moving Average | $4.51(4.99%) | To recent high | -46.1% | To recent low | 65.8% | Market Cap | $352m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |